Busam Klaus J, Duncan Lyn M, Gerami Pedram, Lowe Lori, Sheikh Hina, Tetzlaff Michael
Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer, New York, New York, USA.
Pathology Service, Dermatopathology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
J Cutan Pathol. 2025 Oct;52(10):655-660. doi: 10.1111/cup.14848. Epub 2025 Jul 31.
Guidelines have been proposed for the pathology reporting of melanoma to ensure inclusion of data elements important for patient care. Compliance with guidelines has been made a yardstick for quality performance. However, there is controversy about how comprehensive a report must be, which is why the American Society of Dermatopathology has formed a task force with the goal of defining minimum data elements that should be included in a pathology report of a primary cutaneous melanoma. Importantly, additional information can or at times should be documented if a pathologist believes it is valuable to the clinical care team of a particular patient. The proposed minimum reporting guidelines outlined herein largely reflect core reporting elements by various professional organizations. Data elements must be included if they are needed for pathologic staging. Excisions require a margin status, but detailed margin metrics are not required for most cases. Furthermore, histopathologic subtyping of melanoma in situ is not routinely needed. Whether or not invasive melanoma should be subclassified depends on clinical relevance and whether the available evidence permits a definitive melanoma subclassification. When the minimum data elements are included, a pathology report should be considered compliant with quality reporting guidelines.
已提出黑色素瘤病理报告的指南,以确保纳入对患者护理至关重要的数据元素。遵守指南已成为质量绩效的衡量标准。然而,对于报告必须有多全面存在争议,这就是为什么美国皮肤病理学会成立了一个特别工作组,目标是确定原发性皮肤黑色素瘤病理报告中应包含的最低数据元素。重要的是,如果病理学家认为某些信息对特定患者的临床护理团队有价值,那么这些额外信息可以或有时应该记录下来。本文概述的拟议最低报告指南在很大程度上反映了各专业组织的核心报告要素。如果病理分期需要某些数据元素,则必须将其纳入。切除标本需要切缘状态,但大多数情况下不需要详细的切缘测量指标。此外,原位黑色素瘤的组织病理学亚型通常不需要。侵袭性黑色素瘤是否应进行亚分类取决于临床相关性以及现有证据是否允许进行明确的黑色素瘤亚分类。当包含最低数据元素时,病理报告应被视为符合质量报告指南。